These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 26926467)

  • 21. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling.
    Zhou S; Liu Y; Prater K; Zheng Y; Cai L
    Life Sci; 2013 Nov; 93(23):855-62. PubMed ID: 24021888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA in cardiovascular biology and disease.
    Wojciechowska A; Braniewska A; Kozar-Kamińska K
    Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.
    Gangwar RS; Rajagopalan S; Natarajan R; Deiuliis JA
    Am J Hypertens; 2018 Jan; 31(2):150-165. PubMed ID: 29186297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA: A new therapeutic strategy for cardiovascular diseases.
    Samanta S; Balasubramanian S; Rajasingh S; Patel U; Dhanasekaran A; Dawn B; Rajasingh J
    Trends Cardiovasc Med; 2016 Jul; 26(5):407-19. PubMed ID: 27013138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in heart failure: from biomarker to target for therapy.
    Vegter EL; van der Meer P; de Windt LJ; Pinto YM; Voors AA
    Eur J Heart Fail; 2016 May; 18(5):457-68. PubMed ID: 26869172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in Cardiovascular Disease.
    Barwari T; Joshi A; Mayr M
    J Am Coll Cardiol; 2016 Dec; 68(23):2577-2584. PubMed ID: 27931616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Aghabozorgi AS; Ahangari N; Eftekhaari TE; Torbati PN; Bahiraee A; Ebrahimi R; Pasdar A
    J Cell Physiol; 2019 Dec; 234(12):21796-21809. PubMed ID: 31273798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives.
    Sessa F; Salerno M; Esposito M; Cocimano G; Pomara C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in cardiovascular disease.
    Gurha P
    Curr Opin Cardiol; 2016 May; 31(3):249-54. PubMed ID: 26885771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic advances in MicroRNA targeting.
    Montgomery RL; van Rooij E
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNAs in Heart Development and Disease.
    Lozano-Velasco E; Inácio JM; Sousa I; Guimarães AR; Franco D; Moura G; Belo JA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in bone diseases.
    Gennari L; Bianciardi S; Merlotti D
    Osteoporos Int; 2017 Apr; 28(4):1191-1213. PubMed ID: 27904930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of microRNAs in cardiac remodeling and heart failure.
    Topkara VK; Mann DL
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):171-82. PubMed ID: 21431305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of microRNAs in cardiac hypertrophy and heart failure.
    Wang N; Zhou Z; Liao X; Zhang T
    IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.
    van Rooij E; Olson EN
    Nat Rev Drug Discov; 2012 Nov; 11(11):860-72. PubMed ID: 23080337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.